Segurança de medicamentos, estatinas, uso racional de medicamentos

Morgan TK, Williamson M, Pirotta M, Stewart K, Myers

SP, Barnes J. A national census of medicines use:

a 24-hour snapshot of Australians aged 50 years and

older. Med J Aust 2012;196:50-3.

Kronmal RA, Cain KC, Ye Z, Omenn GS. Total serum

cholesterol levels and mortality risk as a function of age.

A report based on the Framingham data. Arch Intern

Med 1993;153:1065-73.

Lewington S , Whitlock G, Clarke R, Sherliker P, Emberson

J, Halsey J, et al. Blood cholesterol and vascular

mortality by age, sex, and blood pressure: a meta-analysis

of individual data from 61 prospective studies with

,000 vascular deaths. Lancet 2007;370:1829-39.

Afilalo J, Duque G, Steele R, Jukema JW, De Craen

AJ, Eisenberg MJ. Statins for secondary prevention in

elderly patients: a hierarchical Bayesian meta-analysis. J

Am Coll Cardiol 2008;51:37-45.

Baigent C, Keech A, Kearney PM, Blackwell L, Buck

G, Pollicino C, et al. Efficacy and safety of cholesterollowering

treatment: prospective meta-analysis of data

from 90,056 participants in 14 randomised trials of

statins. Lancet 2005;366:1267-78.

Lacroix AZ, Gray SL, Aragaki A, Cochrane BB, Newman

AB, Kooperberg CL, et al. Statin use and incident

frailty in women aged 65 years or older: prospective findings

from the Women’s Health Initiative Observational

Study. J Gerontol A Biol Sci Med Sci 2008;63:369-75.

Gnjidic D, Le Couteur DG, Blyth FM, Travison T, Rogers

K, Naganathan V, et al. Statin use and clinical outcomes

in older men: a prospective population-based

study. BMJ Open 2013;3:e002333.

McGuinness B, Craig D, Bullock R, Passmore P.

Statins for the prevention of dementia. Cochrane Database

Syst Rev 2009;2:CD003160.

McGuinness B, O’Hare J, Craig D, Bullock R, Malouf

R, Passmore P. Statins for the treatment of dementia.

Cochrane Database Syst Rev 2010;8:CD007514.

Padala KP, Padala PR, McNeilly DP, Geske JA, Sullivan

DH, Potter JF. The effect of HMG-CoA reductase

inhibitors on cognition in patients with Alzheimer’s dementia:

a prospective withdrawal and rechallenge pilot

study. Am J Geriatr Pharmacother 2012;10:296-302.

Law MR, Wald NJ, Rudnicka AR. Quantifying effect

of statins on low density lipoprotein cholesterol, ischaemic

heart disease, and stroke: systematic review and

meta-analysis. BMJ 2003;326:1423.

Zhou Z, Rahme E, Abrahamowicz M, Tu JV, Eisenberg

MJ, Humphries K, et al. Effectiveness of statins for

secondary prevention in elderly patients after acute

myocardial infarction: an evaluation of class effect.

CMAJ 2005;172:1187-94.

Pasternak RC, Smith SC Jr, Bairey-Merz CN, Grundy

SM, Cleeman JI, Lenfant C. ACC/AHA/NHLBI clinical

advisory on the use and safety of statins. Circulation

;106:1024-8.

Sattar N, Preiss D, Murray HM, Welsh P, Buckley BM,

De Craen AJ, et al. Statins and risk of incident diabetes:

a collaborative meta-analysis of randomized statin trials.

Lancet 2010;375:735-42.

Evans MA, Golomb BA. Statin-associated adverse

cognitive effects: survey results from 171 patients. Pharmacotherapy

;29:800-11.

King DS, Wilburn AJ, Wofford MR, Harrell TK, Lindley

BJ, Jones DW. Cognitive impairment associated

with atorvastatin and simvastatin. Pharmacotherapy

;23:1663-7.

Wagstaff LR, Mitton MW, Arvik BM, Doraiswamy

PM. Statin-associated memory loss: analysis of 60 case

reports and review of the literature. Pharmacotherapy

;23:871-80.

Golomb BA, Evans MA, Dimsdale JE, White HL. Effects

of statins on energy and fatigue with exertion:

results from a randomized controlled trial. Arch Intern

Med 2012;172:1180-2.